Introduction
============

Platelet-rich plasma (PRP), an autologous derivative of whole blood that contains concentrated platelets, has been advocated as a way to introduce increased concentrations of growth factors that are known to have beneficial effects on tissue regeneration, including platelet-derived growth factor (PDGF), transforming growth factor (TGF), insulin-like growth factor (IGF) and vascular endothelial growth factor (VEGF) ([@b1-etm-0-0-4726]), to injured tissue in an attempt to aid in tissue regeneration ([@b2-etm-0-0-4726]--[@b5-etm-0-0-4726]). However, leukocytes in PRP release pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) to counteract the beneficial effects of growth factors on tissue regeneration ([@b6-etm-0-0-4726]--[@b8-etm-0-0-4726]). Consequently, effort has been put into the depletion of leukocytes from PRP to prepare pure PRP (P-PRP) over the past few years.

Multiple systems have been developed to offer an easy, cost-effective strategy to prepare P-PRP, including selective blood filtration methods ([@b7-etm-0-0-4726],[@b9-etm-0-0-4726]) and centrifugation methods ([@b3-etm-0-0-4726],[@b10-etm-0-0-4726],[@b11-etm-0-0-4726]). The latter are widely used due to their feasibility and comparatively lower cost ([@b12-etm-0-0-4726]). The basic principle of preparing P-PRP with centrifugation methods is that it allows platelets to settle and to concentrate in the lower layer of the plasma, and therefore to become separated from the upper layer. In addition, erythrocytes and leukocytes settle faster than platelets, allowing for individual separation from plasma ([@b13-etm-0-0-4726]). This phenomenon is governed by Stokes\' law ([@b14-etm-0-0-4726]), which states that the sedimentation rates of particles in a liquid environment are positively correlated to the mass of particles and the sedimentation force the particles are exposed to. Regarding P-PRP preparation, a greater centrifugal force enhances the sedimentation force and hence the difference of the sedimentation rates between erythrocytes, leukocytes and platelets, and a longer centrifugal duration enhances the sedimentation duration and hence guarantees the capture and enrichment of platelets due to the difference in the sedimentation rate. A great centrifugal force and long centrifugal duration separates platelets from the plasma to form a 'buffy coat' together with leukocytes and hence, they are unable to be separated from leukocytes. Thus, the currently used centrifugal conditions to prepare P-PRP require to be optimized ([@b10-etm-0-0-4726],[@b15-etm-0-0-4726]). Although the cellular characteristics of PRP obtained using different preparation systems have been evaluated by numerous studies in order to identify the optimal centrifugal conditions for the preparation of leukocyte-rich PRP and P-PRP, the cellular characterization of PRP is typically limited to PRP obtained using currently available preparation systems that have been developed to date, while the optimal centrifugal conditions may have remained to be determined ([@b10-etm-0-0-4726]).

The first purpose of the present study was to identify the optimal centrifugal conditions to capture and concentrate platelets while depleting erythrocytes and leukocytes. As the optimal centrifugal conditions for platelet capture and enrichment may be different ([@b10-etm-0-0-4726],[@b15-etm-0-0-4726]), double-spin methods were applied to capture platelets with the first spin and concentrate them further with the second spin. As cytokines released from platelets and leukocytes are thought to be the effective components of PRP, the second purpose of the study was to evaluate cytokine concentrations in P-PRP obtained using different conditions and the correlations between cytokine concentrations and the cellular characteristics of P-PRP. The third purpose of the study was to evaluate the *in vitro* effects of P-PRP obtained using different conditions on cells.

Materials and methods
=====================

### Subjects

The study was performed in accordance with the principles of the Declaration of Helsinki. The Independent Ethics Committee of the Sixth People\'s Hospital Affiliated to Shanghai Jiao Tong University (Shanghai, China) approved the study protocols for collecting samples and their use for scientific experiments.

A total of 80 healthy volunteers (46 men and 34 women; age, 21--60 years) were included in the study for blood donation. Healthy adults who agreed to participate in the study and gave informed consent were included. The exclusion criterion was a medical history of relevant diseases or consumption of any medications known to affect platelet function or concentration for 21 days prior to blood collection.

Volunteers were randomly divided into two groups (n=40). The blood collected from volunteers of the single-spin group was used to identify the optimal centrifugal conditions for the first spin and the blood collected from volunteers of the double-spin group was used to identify the optimal centrifugal conditions for the second spin.

### Blood collection

Approximately 216 ml venous blood collected by a licensed phlebotomist using a 19-gauge blood collection needle was added into 24 ml of acid-citrate dextrose solution A anti-coagulant to prepare 240 ml of anti-coagulated whole blood for each volunteer. A single-donor model was applied to minimize potential confounding variables ([@b1-etm-0-0-4726]). The anti-coagulated whole blood was split into six aliquots of 40 ml in 50-ml centrifuge tubes (Corning, Lowell, MA, USA) and subjected to the first spin within 30 min after collecting in an automated tabletop centrifuge (Ankel TDL-5-A; Anting Scientific Instrument Factory, Shanghai, China). A blood collection tube coated with K2 EDTA (BD Vacutainer; BD Biosciences, Franklin Lakes, NJ, USA) was used to collect 2 ml of venous blood for whole-blood analysis.

### Centrifugal conditions for the first spin

In existing systems, a centrifugal duration of 10--15 min is most frequently applied and short enough to be acceptable in clinical practice; therefore, it was selected as the centrifugal duration for the first and the second spin. Based on the results of a previous study, centrifugal conditions of \<110 × g for 15 min cannot separate erythrocytes and leukocytes from concentrated platelets, while a centrifugal force \>180 × g for 10 min separates platelets from plasma to form a 'buffy coat' together with leukocytes and hence they are unable to be separated from leukocytes (unpublished data). Thus, in the present study, the first spin was performed at 110 × g for 15 min (110×15), 130×10, 130×15, 160×10, 160×15 or 180×10 at room temperature.

After the first spin, the blood was separated into three components: Erythrocytes at the bottom, buffy coat in the middle and platelet-containing plasma (PCP) at the top. Although the buffy coat contains concentrated platelets, it also contains concentrated leukocytes. Thus, the bottom and middle layers were discarded to deplete leukocytes and erythrocytes, and the PCP was transferred to a new tube and subjected to the second spin to prepare P-PRP in the second-spin group, which was collected and measured for volume by gentle aspiration with a 5-ml graduated pipette (Jet Biofil, Guangzhou, China). All procedures were performed by the same operator (WY).

### Centrifugal conditions for the second spin

The first spin was performed under the optimal conditions according to the results of the test for conditions for the first spin. After the first spin, PCP was collected by gentle aspiration and transferred to a new 50-ml centrifuge tube. Care was taken to avoid contamination of buffy coat and erythrocytes. Based on the results of a previous study ([@b10-etm-0-0-4726]), the optimal centrifugal conditions to concentrate platelets may be 250×15 and therefore, the second spin was performed at 180×10, 180×15, 250×10, 250×15, 450×10 or 450×15 at room temperature. After the second spin, the supernatant platelet-poor plasma was discarded by gentle aspiration. Subsequently, the pellets containing platelets were resuspended in the residual supernatant to obtain a total of 4 ml of P-PRP. All procedures were performed by the same operator (HX).

### Whole-blood analysis

Whole-blood analysis was performed using an automatic hematology analyzer (XS-800i; Sysmex, Kobe, Japan) in the clinical laboratory of the hospital to determine the concentration of erythrocytes, leukocytes and platelets in the whole blood, PCP obtained by different first-spin conditions and P-PRP obtained by different second-spin conditions. Platelet capture efficiencies, platelet enrichment factors, leukocyte-reducing efficiencies and erythrocyte-reducing efficiencies of PCP and P-PRP were calculated according to formulas given in [Fig. 1](#f1-etm-0-0-4726){ref-type="fig"}.

### Analysis of platelet activation status

Platelet activation statuses of PCP obtained from different first-spin conditions and P-PRP obtained from different second-spin conditions under basal conditions and after incubation with 200 µM adenosine diphosphate (ADP; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) were analyzed to evaluate platelet function ([@b10-etm-0-0-4726]). In brief, PCP and P-PRP under basal condition or after incubation with 200 µM ADP for 5 min at room temperature were incubated with fluorescein isothiocyanate (FITC)-labeled anti-CD62P (BD Pharmingen, Oxford, UK) or FITC-labeled control antibody (BD Pharmingen) for 30 min at room temperature. The platelet activation statuses of PCP and P-PRP under basal conditions and after exogenous activation were determined by assessing the CD62P expression rates of platelets by flow cytometry and guavaSoft (Guava easyCyte 8HT flow cytometry system; Millipore, Billerica, MA, USA).

### Quantification of cytokine concentrations in PCP and P-PRP

PCP obtained from different first-spin conditions and P-PRP obtained using different second-spin conditions were activated with 10% CaCl~2~ (final concentration, 22.8 mM). Subsequently, the formulations were incubated at 37°C in a humidified atmosphere with 5% CO~2~ for 2 h. At the end of the incubation period, the formulations were centrifuged at 2,800×15 and the supernatant was collected and stored at −80°C until analysis. The supernatant was assayed for IL-1β, tumor necrosis factor (TNF)-α, platelet-derived growth factor (PDGF)-AB and transforming growth factor (TGF)-β1 with Quantikine Human Immunoassay kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer\'s protocol.

### Isolation and culture of cells

Human bone marrow-derived mesenchymal stem cells (hBMSCs) were isolated as described elsewhere ([@b16-etm-0-0-4726]). In brief, bone marrow aspirates were harvested from the greater trochanter during femur fracture surgery, anti-coagulated with preservative-free heparin (1,000 U/ml), filtered with a 70-mm filter mesh and suspended in α-modification of minimum essential medium (Sigma-Aldrich; Merck KGaA) containing 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 1% antibiotics (penicillin G and streptomycin; Gibco; Thermo Fisher Scientific, Inc.) at 37°C in a humidified atmosphere containing 5% CO~2~. The medium was changed after 48 h to remove non-adherent cells and thereafter every three days. Cells of the third passage were used for this study.

Human articular chondrocytes (hACs) were isolated according to the protocol of a previous study ([@b17-etm-0-0-4726]). In brief, articular cartilage samples were obtained from patients undergoing total knee replacement surgery, minced into small pieces and digested with collagenase II (Sigma-Aldrich; Merck KGaA). The released hACs were then cultured in 6-well plates at a density of 2.5×10^5^ cells/well in Dulbecco\'s modified Eagle\'s medium/Ham\'s F-12 50/50 mix (Corning, Inc., Corning, NY, USA) containing 10% FBS and 1% antibiotics at 37°C in a humidified atmosphere with 5% CO~2~. The medium was changed after 48 h to remove non-adherent cells and every three days thereafter. Cells of the third passage were used for this study.

### Cell proliferation assay

Cells were seeded in 96-well plates at a density of 4,000 cells/well and cultured for 24 h in FBS-free medium. Cells were then cultured in medium supplemented with 10% (volume/volume) of P-PRP obtained from different conditions for seven days. The proliferation of cells grown in the presence of P-PRP formulations was evaluated on days 1, 4 and 7 using a Cell Counting Kit-8 (CCK-8, Dojindo, Kumamoto, Japan) according to the manufacturer\'s instructions. In brief, 10 µl CCK-8 solution was added to each well containing 100 µl medium and incubated for 3 h. The absorbance value was measured with a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) at 450 nm.

### Cell survival analysis

Cells were seeded in 6-well plates at a density of 1×105 cells/well, serum-starved for 24 h and cultured in medium supplemented with 10% P-PRP obtained from different conditions for seven days. Cells were then subjected to live/dead staining using a Cell Viability Imaging kit (Thermo Fisher Scientific, Inc.) according to the manufacturer\'s instructions. The survival of cells was observed using an inverted microscope (Leica, Wetzlar, Germany) and counted in five randomly selected fields per well.

### Cell migration analysis

Effects of P-PRP formulations on cell migration were evaluated using a Transwell assay as described previously ([@b18-etm-0-0-4726]). In brief, confluent cells were serum-starved for 24 h, detached by 0.25% trypsin-EDTA (Invitrogen; Thermo Fisher Scientific, Inc.) and seeded at a density of 1×105/well in the upper chambers of 24-well Transwell systems (Corning, Inc.). Medium containing 10% P-PRP obtained from different conditions was then added into the lower chambers. After 24 h of incubation, the cells on the upper surface of the membranes were removed with a cotton swab and the cells migrated to the lower surface were fixed with 4% paraformaldehyde, stained using 0.5% crystal violet for 10 min, observed using an microscope and counted on five randomly selected fields per membrane.

### Statistical analysis

Data were analyzed using the Statistical Package for Social Sciences version 22.0 (IBM SPSS, Armonk, NY, USA). Values are expressed as the mean ± standard deviation or number of volunteers as appropriate. The independent-samples Student\'s t-test was performed to analyze differences in continuous data between the single- or double-spin groups and the chi-square test was used to analyze the difference between groups regarding gender. One-way analysis of variance and Bonferroni\'s post-hoc test were performed to analyze the difference in continuous data among conditions. Pearson correlation analysis was conducted to analyze linear correlations between variables. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### General information of subjects and blood cell concentrations

General information and blood cell concentrations of volunteers are listed in [Table I](#tI-etm-0-0-4726){ref-type="table"}. No statistically significant differences were found between the single-spin group and the double-spin group regarding all variables.

### Characteristics of PCP obtained from different first-spin conditions

The volume of PCP obtained from 160×10 was significantly higher than that obtained from 110×15 (P\<0.001) and comparable with that obtained by 130×10 (P=0.096), 130×15 (P\>0.999), 160×15 (P\>0.999) and 180×10 (P=0.189; [Fig. 2A](#f2-etm-0-0-4726){ref-type="fig"}).

The platelet concentration of PCP obtained using 160×10 was significantly higher than that of PCP obtained using 110×15 (P\<0.001), 130×10 (P\<0.001), 160×15 (P\<0.001) and 180×10 (P\<0.001), and comparable with that obtained using 130×15 (P\>0.999; [Fig. 2B](#f2-etm-0-0-4726){ref-type="fig"}). Similarly, the platelet enrichment factor of PCP obtained using 160×10 was significantly higher than that of PCP obtained from 110×15 (P\<0.001), 130×10 (P\<0.001), 160×15 (P\<0.001) and 180×10 (P\<0.001), and was not significantly different from that obtained from 130×15 (P\>0.999; [Fig. 2C](#f2-etm-0-0-4726){ref-type="fig"}).

The platelet capture efficiency of PCP obtained using 160×10 was significantly higher than that obtained from 110×15 (P\<0.001), 130×10 (P\<0.001), 130×15 (P\<0.001), 160×15 (P\<0.001) and 180×10 (P\<0.001; [Fig. 2D](#f2-etm-0-0-4726){ref-type="fig"}).

PCP obtained using different conditions had comparable leukocyte concentrations (P=0.214; [Fig. 2E](#f2-etm-0-0-4726){ref-type="fig"}), erythrocyte concentrations (P=0.146; [Fig. 2F](#f2-etm-0-0-4726){ref-type="fig"}), leukocyte-reducing efficiencies (P=0.400; [Fig. 2G](#f2-etm-0-0-4726){ref-type="fig"}), erythrocyte-reducing efficiencies (P=0.634; [Fig. 2H](#f2-etm-0-0-4726){ref-type="fig"}), basal CD62P expression rates of platelets (P=0.451; [Fig. 2I](#f2-etm-0-0-4726){ref-type="fig"}) and ADP-induced CD62P expression rates of platelets (P=0.304; [Fig. 2J](#f2-etm-0-0-4726){ref-type="fig"}).

Similar to the results on the platelet capture efficiency, PCP obtained using 160×10 had the highest PDGF-AB concentration compared to that obtained using 110×15 (P\<0.001), 130×10 (P\<0.001), 130×15 (P=0.027), 160×15 (P\<0.001) and 180×10 (P\<0.001; [Fig. 3A](#f3-etm-0-0-4726){ref-type="fig"}). In addition, PCP obtained using 160×10 had the highest TGF-β1 concentration compared with that in PCP obtained using 110×15 (P\<0.001), 130×10 (P\<0.001), 130×15 (P=0.037), 160×15 (P\<0.001) and 180×10 (P\<0.001; [Fig. 3B](#f3-etm-0-0-4726){ref-type="fig"}).

Similar to the results on the erythrocyte- and leukocyte-associated characteristics of PCP, the differences in IL-1β and TNF-α concentrations among conditions were not significant (P=0.467 and P=0.461, respectively; [Fig. 3C and D](#f3-etm-0-0-4726){ref-type="fig"}).

The aforementioned results demonstrated that, compared with other conditions, centrifugation at 160×10 had the highest platelet capture efficiency and achieved the highest growth factor concentrations, while the concentration and reducing efficiency of leukocytes and erythrocytes, pro-inflammatory cytokine concentrations and platelet activation status were similar to those obtained by other conditions. In addition, the platelet concentration and platelet enrichment factor of PCP obtained by 160×10 were higher than those obtained using other conditions except 130×15. Therefore, 160×10 was designated as the optimal centrifugation conditions for the first spin.

### Characteristics of P-PRP obtained using different second-spin conditions

As shown in [Fig. 4A](#f4-etm-0-0-4726){ref-type="fig"}, the volumes of P-PRP obtained from different conditions were constant (P=0.563; [Fig. 4A](#f4-etm-0-0-4726){ref-type="fig"}). One-way analysis of variance indicated that the difference in platelet concentration of P-PRP among the conditions was significant (P=0.003). However, the Bonferroni post-hoc test was unable to identify any significant difference between conditions (P\>0.05; [Fig. 4B](#f4-etm-0-0-4726){ref-type="fig"}). The platelet enrichment factor of P-PRP obtained using 250×15 was significantly higher than that obtained using 180×10 (P\<0.001), 180×15 (P\<0.001) and 250×10 (P\<0.001). However, the platelet enrichment factor did not further increase by preparation using 450×10 (P\>0.999) and 450×15 (P\>0.999) compared with 250×15 ([Fig. 4C](#f4-etm-0-0-4726){ref-type="fig"}).

The platelet capture efficiency of P-PRP obtained by centrifugation at 250×15 was significantly higher than that obtained at 180×10 (P\<0.001), 180×15 (P\<0.001) and 250×10 (P\<0.001). Similar to the results on the platelet enrichment factor of P-PRP, the platelet capture efficiency did not further increase by preparation using 450×10 (P\>0.999) and 450×15 (P\>0.999; [Fig. 4D](#f4-etm-0-0-4726){ref-type="fig"}).

Similar to the results of the first spin, P-PRP obtained using different conditions provided comparable leukocyte concentrations (P=0.839; [Fig. 4E](#f4-etm-0-0-4726){ref-type="fig"}), erythrocyte concentrations (P=0.997; [Fig. 4F](#f4-etm-0-0-4726){ref-type="fig"}), leukocyte-reducing efficiencies (P=0.753; [Fig. 4G](#f4-etm-0-0-4726){ref-type="fig"}), erythrocyte-reducing efficiencies (P=0.998; [Fig. 4H](#f4-etm-0-0-4726){ref-type="fig"}) and basal CD62P expression rates of platelets (P=0.650; [Fig. 4I](#f4-etm-0-0-4726){ref-type="fig"}). However, the ADP-induced CD62P expression rate of platelets in P-PRP obtained by centrifugation at 250×15 was significantly higher than that obtained at 450×10 (P=0.031) and 450×15 (P\<0.001), but was comparable with that obtained at 180×10 (P\>0.999), 180×15 (P\>0.999) and 250×10 (P\>0.999; [Fig. 4J](#f4-etm-0-0-4726){ref-type="fig"}).

P-PRP obtained by centrifugation at 250×15 had a higher level of PDGF-AB compared to that obtained at 180×10 (P=0.001), 180×15 (P=0.028), 250×10 (P=0.008), 450×10 (P=0.011) and 450×15 (P=0.004; [Fig. 5A](#f5-etm-0-0-4726){ref-type="fig"}). Similarly, P-PRP obtained at 250×15 had the highest level of TGF-β1 compared with that obtained at 180×10 (P=0.036), 180×15 (P=0.007), 250×10 (P=0.001), 450×10 (P=0.002) and 450×15 (P\<0.001; [Fig. 5B](#f5-etm-0-0-4726){ref-type="fig"}). Similar to the results regarding the leukocyte- and erythrocyte-associated characteristics of P-PRP, that obtained using different conditions had comparable concentrations of IL-1β (P=0.695; [Fig. 5C](#f5-etm-0-0-4726){ref-type="fig"}) and TNF-α (P=0.689; [Fig. 5D](#f5-etm-0-0-4726){ref-type="fig"}).

While providing comparable concentrations and reducing efficiencies of leukocytes and erythrocytes, pro-inflammatory cytokine concentrations and the basal platelet activation status to those obtained using other conditions, centrifugation at 250×15 enhanced the capture efficiency and enrichment factor of platelets of P-PRP to similar levels of those obtained using harder conditions (450×10 and 450×15) and diminished the harmful effects of centrifugation on the ADP-induced CD62P expression rates of platelets in P-PRP to similar levels of those achieved by softer conditions (180×10, 180×15 and 250×10). In addition, P-PRP obtained using 250×15 had the highest growth factor concentrations compared with that obtained using other conditions. Therefore, the optimal centrifugation conditions for the second spin were determined to be 250×15.

### Correlation between cytokine concentrations and the cellular characteristics of P-PRP

Significant positive correlations were observed between the PDGF-AB concentration in P-PRP and the platelet capture efficiency (r=0.133, P=0.039; [Fig. 6A](#f6-etm-0-0-4726){ref-type="fig"}), platelet enrichment factor (r=0.159, P=0.014; [Fig. 6B](#f6-etm-0-0-4726){ref-type="fig"}), the platelet concentration (r=0.532, P\<0.001; [Fig. 6C](#f6-etm-0-0-4726){ref-type="fig"}) and the ADP-induced CD62P expression rate of platelets (r=0.542, P\<0.001; [Fig. 6D](#f6-etm-0-0-4726){ref-type="fig"}).

Significant positive correlations were also observed between the TGF-β1 concentration of P-PRP and the platelet capture efficiency (r=0.130, P=0.044; [Fig. 6E](#f6-etm-0-0-4726){ref-type="fig"}), platelet enrichment factor (r=0.158, P=0.014; [Fig. 6F](#f6-etm-0-0-4726){ref-type="fig"}), platelet concentration (r=0.493, P\<0.001; [Fig. 6G](#f6-etm-0-0-4726){ref-type="fig"}) and the ADP-induced CD62P expression rate of platelets in P-PRP (r=0.555, P\<0.001; [Fig. 6H](#f6-etm-0-0-4726){ref-type="fig"}).

Furthermore, significant positive correlations were observed between the leukocyte concentration and the concentration of IL-1β (r=0.898, P\<0.001; [Fig. 7A](#f7-etm-0-0-4726){ref-type="fig"}) and TNF-α in P-PRP (r=0.863, P\<0.001; [Fig. 7B](#f7-etm-0-0-4726){ref-type="fig"}). Significant negative correlations were observed between the leukocyte-reducing efficiency of P-PRP and the concentration of IL-1β (r=−0.803, P\<0.001; [Fig. 7C](#f7-etm-0-0-4726){ref-type="fig"}) and TNF-α in P-PRP (r=−0.774, P\<0.001; [Fig. 7D](#f7-etm-0-0-4726){ref-type="fig"}).

### Effects of P-PRP obtained using different conditions on cells in vitro

The proliferation of hBMSCs in the presence of P-PRP obtained using different conditions was comparable on day 1 (P=0.724; [Fig. 8A](#f8-etm-0-0-4726){ref-type="fig"}). However, compared with P-PRP obtained using other conditions, that obtained by second-spin centrifugation at 250×15 significantly promoted the proliferation of hBMSCs after incubation for 4 days (P=0.001) and 7 days (P\<0.001). Similar results were also observed regarding the proliferation of hACs in the presence of P-PRP, which was comparable between groups on day 1 (P=0.805; [Fig. 8B](#f8-etm-0-0-4726){ref-type="fig"}) and significantly enhanced by P-PRP obtained by second-spin centrifugation at 250×15 on day 4 (P=0.028) and day 7 (P=0.005).

The live/dead staining results for hBMSCs and hACs are shown in [Fig. 8C](#f8-etm-0-0-4726){ref-type="fig"}. Quantified analysis revealed that P-PRP obtained using 250×15 maintained the survival of hBMSCs and hACs to a comparable extent to P-PRP obtained using other conditions (P=0.384 and P=0.627, respectively; [Fig. 8D](#f8-etm-0-0-4726){ref-type="fig"}).

Representative images of migrated hBMSCs and hACs are shown in [Fig. 9A](#f9-etm-0-0-4726){ref-type="fig"}. Quantified analysis revealed that P-PRP obtained by 250×15 significantly promoted the migration of hBMSCs (P\<0.001) and hACs (P\<0.001; [Fig. 9B](#f9-etm-0-0-4726){ref-type="fig"}) compared with P-PRP obtained obtained using other conditions.

Discussion
==========

The study by Bausset *et al* ([@b10-etm-0-0-4726]) demonstrated that centrifugation at 250×15 min, which is not used by any of the currently existing preparation systems, maximizes platelet enrichment while preserving the bioactivity of platelets. However, this method did not achieve the same platelet enrichment as that in leukocyte- and platelet-rich plasma, which concentrates platelets and leukocytes 4- to 8-fold that of the baseline levels ([@b6-etm-0-0-4726]). The possible reason may be that the centrifugal conditions of the first spin of the system used by Bausset *et al* ([@b10-etm-0-0-4726]), namely 130×15, may not be the optimal conditions to capture platelets ([@b15-etm-0-0-4726]). The results of the present study demonstrated that the first spin at 160×10 captured more platelets than that at 130×15. Therefore, although the optimal centrifugal condition for the second spin determined by the present study (250×15) were in accordance with those of the study by Bausset *et al* ([@b10-etm-0-0-4726]), the higher platelet capture efficiency of the first spin captured more platelets to be concentrated with the second spin, resulting in a P-PRP with a higher platelet concentration and enrichment factor. Therefore, 160×10 may be more appropriate for the first spin than 130×15.

It is well known that the buffy coat contains concentrated leukocytes and complete removal of the buffy coat is necessary to deplete leukocytes from the final PRP obtained ([@b19-etm-0-0-4726]). However, the interface of buffy coat and PCP is not clear and PCP is generally contaminated by a portion of buffy coat. Due to the fact that the buffy coat also contains concentrated platelets, contamination with the buffy coat may result in a higher platelet capture efficiency of the final P-PRP obtained and therefore result in a higher platelet concentration and enrichment factor of the P-PRP obtained. Thus, the completeness of buffy coat removal is a potential confounding variable for the comparison of the effects of centrifugal conditions on the cellular composition of P-PRP obtained. In the present study, the same operator performed all of the procedures for buffy coat removal to avoid artifacts due to the difference of completeness of buffy coat removal. The results demonstrated that PCP and P-PRP obtained using different conditions had similar leukocyte and erythrocyte concentrations. The results revealed that the completeness of buffy coat removal was constant in the process of the experiments. Thus, it is plausible to conclude that the different platelet-associated characteristics of P-PRP from different centrifugal conditions resulted from the difference of centrifugal conditions, rather than the difference in the completeness of buffy coat removal.

Both PDGF-AB and TGF-β1 have been shown to be desirable in tissue healing ([@b1-etm-0-0-4726],[@b13-etm-0-0-4726],[@b20-etm-0-0-4726]--[@b22-etm-0-0-4726]). Therefore, the present study assessed PDGF-AB and TGF-β1 concentrations in PCP and P-PRP obtained using different conditions. The results demonstrated that the first spin at 160×10, which captured more platelets than the other conditions for the first spin, further concentrated growth factors. Different from the results of the first spin, even though the second spin at 250×15 neither captured more platelets nor concentrated platelets further than harder conditions for the second spin (450×10 and 450×15), it achieved a further concentration of growth factors. The possible reason for this phenomenon may be that the concentrations of growth factors are associated not only with the concentrations, enrichment factors and capture efficiencies of platelets ([@b1-etm-0-0-4726],[@b8-etm-0-0-4726]), but also with the exogenous activation-induced CD62P expression rates ([@b23-etm-0-0-4726]), as demonstrated by previous studies as well as the correlation analysis of the present study. Hence, the lower ADP-induced CD62P expression rates of platelets in P-PRP obtained by using 450×10 and 450×15 and the lower concentrations, enrichment factors and capture efficiencies of platelets in P-PRP obtained using 180×10, 180×15 and 250×15 may account for the lower concentrations of growth factors. Therefore, the preservation of the platelet reactivity to exogenous activation may have an equally important role as the enrichment and capture of platelets in P-PRP preparation ([@b24-etm-0-0-4726]).

IL-1β and TNF-α are the primary cytokines for inflammation and matrix degradation ([@b8-etm-0-0-4726],[@b13-etm-0-0-4726],[@b20-etm-0-0-4726],[@b25-etm-0-0-4726]). Therefore, the present study also assessed the concentration of IL-1β and TNF-α in PCP and P-PRP obtained using different conditions. The results demonstrated that centrifugation at 160×10 and 250×15 achieved leukocyte concentrations, leukocyte-reducing efficiencies, IL-1β concentration and TNF-α concentration in P-PRP similar to those obtained using other conditions. The results of the correlation analysis were in accordance with those of previous studies demonstrating that the leukocyte reduction resulted in decreased concentrations of pro-inflammatory cytokines ([@b1-etm-0-0-4726],[@b8-etm-0-0-4726]). The results implied that buffy coat removal employed by the present study was the crucial factor for the reduction of pro-inflammatory cytokines and that the centrifugal conditions may not have influenced the reduction of leukocytes and pro-inflammatory cytokines as long as the buffy coat was discarded. Therefore, centrifugation at 160×10 and 250×15 with removal of the buffy coat as a crucial step may theoretically be the optimal method for preparing P-PRP.

However, the optimal P-PRP for tissue healing is not born with the optimal P-PRP preparation system. There is no consensus on the optimal platelet concentration of PRP for tissue healing and certain authors suggested that the optimal platelet concentration and enrichment for healing of each tissue may be different ([@b13-etm-0-0-4726]). PRP has been widely used in the treatment of bone defects ([@b26-etm-0-0-4726],[@b27-etm-0-0-4726]), osteochondral defects ([@b28-etm-0-0-4726],[@b29-etm-0-0-4726]) and arthritis ([@b30-etm-0-0-4726],[@b31-etm-0-0-4726]). Therefore, hBMSCs and hACs were selected to evaluate the effects of P-PRP *in vitro*. The results demonstrated that P-PRP obtained using the optimal conditions significantly promoted the proliferation and migration of hBMSCs and hACs compared with P-PRP obtained using other conditions. Numerous studies have demonstrated that the promotion of proliferation and migration of hBMSCs is beneficial for the regeneration of bone ([@b25-etm-0-0-4726]) and cartilage ([@b32-etm-0-0-4726]) and that the promotion of proliferation and migration of hACs is beneficial for the treatment of arthritis ([@b33-etm-0-0-4726]). Therefore, P-PRP obtained using the optimal conditions identified may also be more effective in the treatment of bone defects, osteochondral defects and arthritis. However, further studies are required to substantiate this *in vivo* and *in vitro*.

In conclusion, while P-PRP obtained using different centrifugal conditions had similar erythrocyte, leukocyte and pro-inflammatory cytokine concentrations, centrifugation at 160×10 and 250×15 successively captured and concentrated platelets and growth factors more efficiently with preservation of platelet function compared with other conditions. Moreover, P-PRP obtained using the optimal conditions significantly promoted the proliferation and migration of cells and did not alter cell survival compared with P-PRP obtained from other conditions. Therefore, centrifugation at 160×10 and 250×15 successively with removal of the buffy coat as a crucial step may be able to provide an optimal method for the preparation of P-PRP for clinical application.

The present study was supported by the National Natural Science Foundation of China (grant no. 81401799) and the Shanghai Youth Start-up Grant (grant no. 14YF1412100).

![Formulas for the calculation of the characteristics of PCP and P-PRP. PCP, platelet-containing plasma; P-PRP, pure platelet-rich plasma.](etm-14-03-2060-g00){#f1-etm-0-0-4726}

![Cellular characteristics of platelet-containing plasma obtained using different conditions. (A) Volume, (B) platelet concentration, (C) platelet enrichment factor, (D) platelet capture efficiency, (E) leukocyte concentration, (F) erythrocyte concentration, (G) leukocyte-reducing efficiency, (H) erythrocyte-reducing efficiency, (I) basal CD62P expression rate and (J) ADP-induced CD62P expression rate. Values are expressed as the mean ± standard deviation. \*P\<0.05 compared with 160×10. ADP, adenosine diphosphate; 160×10, centrifugation at 160 × *g* for 10 min.](etm-14-03-2060-g01){#f2-etm-0-0-4726}

![Cytokine concentrations in platelet-containing plasma obtained using different conditions. (A) PDGF-AB, (B) TGF-β1, (C) IL-1β and (D) TNF-α. Values are expressed as the mean ± standard deviation. \*P\<0.05 compared with 160×10. PDGF-AB, platelet-derived growth factor; TGF-β1, transforming growth factor β1; IL-1β, interleukin-1β; TNF-α, tumor necrosis factor-α; 160×10, centrifugation at 160 × *g* for 10 min.](etm-14-03-2060-g02){#f3-etm-0-0-4726}

![Characteristics of pure platelet-rich plasma obtained using different conditions. (A) Volume, (B) platelet concentration, (C) platelet enrichment factor, (D) platelet capture efficiency, (E) leukocyte concentration, (F) erythrocyte concentration, (G) leukocyte-reducing efficiency, (H) erythrocyte-reducing efficiency, (I) basal CD62P expression rate and (J) ADP-induced CD62P expression rate. Values are expressed as the mean ± standard deviation. \*P\<0.05 compared with 250×15. ADP, adenosine diphosphate; 250×15, centrifugation at 250 × *g* for 15 min.](etm-14-03-2060-g03){#f4-etm-0-0-4726}

![Cytokine concentrations of pure platelet-rich plasma obtained using different conditions. (A) PDGF-AB, (B) TGF-β1, (C) IL-1β and (D) TNF-α. Values are expressed as the mean ± standard deviation. \*P\<0.05 compared with 250×15. ADP, adenosine diphosphate; PDGF-AB, platelet-derived growth factor; TGF-β1, transforming growth factor β1; IL-1β, interleukin-1β; TNF-α, tumor necrosis factor-α; 250×15, centrifugation at 250 × *g* for 15 min.](etm-14-03-2060-g04){#f5-etm-0-0-4726}

![Correlation between growth factor concentrations and the characteristics of P-PRP. Positive correlations between the PDGF-AB concentration in P-PRP and (A) the platelet concentration, (B) platelet enrichment factor, (C) platelet capture efficiency and (D) the ADP-induced CD62P expression rate in P-PRP were detected. Furthermore, positive correlations between the TGF-β1 concentration in P-PRP and (E) the platelet concentration, (F) platelet enrichment factor, (G) platelet capture efficiency and (H) the ADP-induced CD62P expression rate in P-PRP were detected. PDGF-AB, platelet-derived growth factor; TGF-β1, transforming growth factor β1; P-PRP, pure platelet-rich plasma; ADP, adenosine diphosphate.](etm-14-03-2060-g05){#f6-etm-0-0-4726}

![Correlations between pro-inflammatory cytokine concentrations and the characteristics of P-PRP. Positive correlations between the leukocyte concentration in P-PRP and (A) the IL-1β concentration and (B) the TNF-α concentration in P-PRP were identified. Negative correlations between the leukocyte-reducing efficiency of P-PRP and (C) the IL-1β concentration and (D) the TNF-α concentration in P-PRP were detected. IL-1β, interleukin-1β; TNF-α, tumor necrosis factor-α; P-PRP, pure platelet-rich plasma.](etm-14-03-2060-g06){#f7-etm-0-0-4726}

![Effects of P-PRP on the proliferation and survival of hBMSCs and hACs. A Cell Counting Kit-8 assay demonstrated that P-PRP obtained by 250×15 centrifugation significantly promoted the proliferation of (A) hBMSCs and (B) hACs after incubation for 4 and 7 days compared with P-PRP obtained using other conditions. (C) Representative images of hBMSCs and hACs subjected to cell viability imaging assay. Viable cells stained blue and dead cells stained green (scale bar, 200 µm). (D) Quantitative analysis of live/dead staining revealed that P-PRP obtained using different conditions had similar effects on the survival of hBMSCs and hACs. Values are expressed as the mean ± standard deviation. \*P\<0.05 compared with 250×15. hBMSCs, human bone marrow-derived mesenchymal stem cells; hACs, human articular chondrocytes; P-PRP, pure platelet-rich plasma; 250×15, second-spin centrifugation at 250 × *g* for 15 min.](etm-14-03-2060-g07){#f8-etm-0-0-4726}

![Pure platelet-rich plasma obtained by 250×15 promoted the migration of hBMSCs and hACs. (A) Migrated hBMSCs and hACs were stained with crystal violet (scale bar, 500 µm); (B) the migration of hBMSCs and hACs was expressed as the number of migrated cells per field. Values are expressed as the mean ± standard deviation. \*P\<0.05 compared with 250×15. 250×15, second-spin centrifugation at 250 × *g* for 15 min; hBMSCs, human bone marrow-derived mesenchymal stem cells; hACs, human articular chondrocytes.](etm-14-03-2060-g08){#f9-etm-0-0-4726}

###### 

General information and blood cell concentrations in blood from grouped volunteers.

  Parameter                               Single-spin group   Double-spin group   P-value
  --------------------------------------- ------------------- ------------------- ---------
  Number of volunteers                    40                  40                  
  Gender (male/female)                    24:16               22:18               0.653
  Age (years)                               40.78±10.18         42.18±10.57       0.548
  Leukocyte concentration (×10^9^/l)        6.24±1.51           6.06±1.50         0.595
  Erythrocyte concentration (×10^12^/l)     4.88±0.51           4.90±0.48         0.867
  Platelet concentration (×10^9^/l)       238.30±36.29        234.25±37.53        0.625

[^1]: Contributed equally
